Urologic Oncology Fellows
Taylor Goodstein, MD
Year 1 Fellow, 2024-2025
Dr. Taylor Goodstein joined the department in 2024 as the first SUO fellow at Emory Urology. She comes from Columbus, Ohio, where she completed her residency at The Ohio State University. At The Ohio State, Dr. Goodstein participated in research projects, wrote review articles on bladder cancer and advanced renal cell carcinoma, and developed QI initiatives for post-vasectomy semen analyses and CT imaging in NSTI. Dr. Goodstein also conducted original research on stent removal after PCNL, which she later presented at the North Central Section of the AUA and World Conference of Endourology.
Dr. Goodstein is from the mountain town of Glenwood Springs, Colorado, where she grew up along the Colorado river, scrambling up and down slopes with her two younger siblings. Mountains have always been an important part of her life and take center stage in many of her experiences of the world. In 2016, she summited Mount Kilimanjaro with the rest of her family, one of her proudest accomplishments.
Before moving to Ohio for residency, she attended medical school in her home state of Colorado at the University of Colorado School of Medicine. She began her path to medicine at Wesleyan University in Middletown, Connecticut, where she double majored in Neuroscience and Biology and minored in Creative Writing. When not studying, she held various leadership positions within her co-ed literary society, Alpha Delta Phi, and performed as part of a long-form improv comedy group, Gag Reflex. Outside of medicine, Dr. Goodstein enjoys reading, painting, and solving puzzles, always accompanied by music and under the watchful eye of her cat, Pippa.
While at Emory Urology, Dr. Goodstein aims to build a career in Urologic Oncology within academia. She is excited about discovering all that the fellowship program has to offer and especially looks forward to the dedicated research year where she hopes to grow her research portfolio and deepen her understanding of urologic oncology. She is particularly interested in testicular cancer, with emphasis on aspects of survivorship. Dr. Goodstein brings her unique perspective to the program and intends to make a lasting impact in the field.